Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Robert L. Reeves"'
Autor:
Robert L. Reeves, Ronald D. Brown, William H. Frishman, Duane G. Wombolt, Brian F. Johnson, Richard Brobyn
Publikováno v:
The American Journal of Cardiology. 73:A50-A54
The efficacy and safety of amlodipine (2.5-10 mg) once daily was compared with atenolol (50-100 mg) once daily in patients with mild-to-moderate essential hypertension in a randomized, double-blind, parallel, placebo-controlled study. A total of 125
Autor:
Ronald D. Brown, Duane G. Wombolt, Brian F. Johnson, Robert L. Reeves, Richard Brobyn, William K. Frishman
Publikováno v:
American Journal of Hypertension. 5:727-732
The efficacy and safety of amlodipine (2.5 mg, 5 mg, or 10 mg) once daily was compared with atenolol (50 mg to 100 mg) once daily in patients with mild-to-moderate essential hypertension in a randomized, double-blind, parallel, placebo-controlled stu
Publikováno v:
American heart journal. 125(5 Pt 2)
Baseline echocardiography was performed on 25 patients with essential hypertension and a supine diastolic blood pressure of 95 to 114 mm Hg while receiving placebo. Once-daily trandolapril was then titrated from 1 to 4 mg. After 3 months of therapy,
Autor:
Sidney Rosenblatt, Jerry M. Herron, Robert L. Reeves, Jean M. Nappi, Donald J. DiPette, Peter E. Pool, Robert R. Evans, Larry V. Staker
Publikováno v:
The American Journal of Cardiology. 62:109-113
The effect of diuretics to increase serum glucose, low-density lipoprotein cholesterol and triglycerides, as well as the adverse changes in triglycerides and high-density lipoprotein cholesterol produced by nonselective beta blockers, have been large
Autor:
Robert L, Reeves
Publikováno v:
Journal of Periodontology. 53:195-198
Publikováno v:
The American Journal of Cardiology. 59:G87-G90
The antihypertensive and lipid effects of doxazosin and atenolol were compared in a 10-week, double-blind, parallel, placebo-controlled study. The 129 adults enrolled had mild to moderate hypertension (average supine diastolic blood pressures for dox
Autor:
Linda K. Corkadel, Lawrence D. Horwitz, Robert L. Reeves, Frances Fan, Richard A. Wright, JoséP. Pacheco
Publikováno v:
The American Journal of Medicine. 81:20-24
The effectiveness of nifedipine as first-line monotherapy for mild diastolic hypertension (range: 95 to 105 mm Hg) was tested in this placebo-controlled, double-blind, randomized trial. Fifty-six patients were enrolled and, after titration of the pla
Autor:
Robert L. Reeves, R A Mulinari, Bruce Garrett, James T. Higgins, James Crook, Alan K. Halperin, Irene Gavras, Edward T. Zawada, Haralambos Gavras
Publikováno v:
The American Journal of Medicine. 83:20-23
The results of a multicenter trial conducted in order to determine the therapeutic efficacy of the gastrointestinal therapeutic system (GITS) formulation of nifedipine in comparison with hydrochlorothiazide and placebo in the management of mild to mo
Autor:
Robert L. Reeves, Brian F. Johnson, William H. Frishman, Ronald D. Brown, Richard Brobyn, Duane G. Wombolt
Publikováno v:
Journal of Cardiovascular Pharmacology. 12:S103-S106
Amlodipine, a new long-acting dihydropyridine calcium antagonist, was compared with placebo and atenolol in 125 patients with mild to moderate systemic hypertension [supine diastolic blood pressure (DBP) 90-114 mm Hg]. Patients received placebo for 4
Autor:
Sidney Rosenblatt, Donald J. DiPette, Peter E. Pool, Jerry M. Herron, Robert R. Evans, Jean M. Nappi, Larry V. Staker, Robert L. Reeves
Publikováno v:
The Journal of Clinical Pharmacology. 29:533-537
The antihypertensive activity of a sustained-release preparation of diltiazem (given each 12 hours) was assessed in 96 patients with supine diastolic blood pressure (BP) between 95 and 110 mm Hg in a multicenter, randomized, double-blind, placebo run